Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Shine News: MAH Program A Shot in the Arm for Chinese Pharmaceutical Industry(3/19/2019 )  (Premium)
Industry News
CanSinoBio to Launch $161M Hong Kong IPO(3/19/2019 )  (Premium)
MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China(3/19/2019 )  (Premium)
ImmunoBiology and CNBG Enter Licensing Pact to Co-Develop Vaccine for Pneumococcal Disease in Greater China(3/19/2019 )  (Premium)
Korean Pharma Il-yang and Hanmi Report Robust Sales Growth in China(3/19/2019 )  (Premium)
Takeda to Invest CNY 110M into Expanding Its Chinese Manufacturing Facility(3/19/2019 )  (Premium)
Merck KGaA Aims to Double China Sales by 2025(3/19/2019 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links